3,5-Dimethoxytoluene

CAS No. 4179-19-5

3,5-Dimethoxytoluene( —— )

Catalog No. M37789 CAS No. 4179-19-5

3,5-Dimethoxytoluene (Orcinol dimethyl ether), the main fragrance component in roses, has a sedative effect and can be used as a pest attractant.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 28 In Stock

Biological Information

  • Product Name
    3,5-Dimethoxytoluene
  • Note
    Research use only, not for human use.
  • Brief Description
    3,5-Dimethoxytoluene (Orcinol dimethyl ether), the main fragrance component in roses, has a sedative effect and can be used as a pest attractant.
  • Description
    3,5-Dimethoxytoluene (Orcinol dimethyl ether), the main fragrance component in roses, has a sedative effect and can be used as a pest attractant.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4179-19-5
  • Formula Weight
    152.19
  • Molecular Formula
    C9H12O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=CC(OC)=CC(C)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cyanidin3-(6-(2-(p)-...

    Cyanidin3-(6-(2-(p)-coumarate-β-D-glucopyranosyl)-β-D-glucopyranosyl)-5-glucopyranoside

  • PACAP (1-38), human,...

    PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), and VIP release. PACAP 1-38 (10-8 M) inhibited gastrin secretion and stimulated somatostatin secretion and motility dose-dependently.

  • Cerdulatinib

    Cerdulatinib is an novel oral dual Syk/JAK inhibitor.